Brandinium

Trademark search for:

ALLOCAR T

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-04-14 — Application filed
  • 2023-04-18 — Application filed
  • 2023-05-09 — Application filed
  • 2023-06-28 — Letter of protest evidence forwarded
  • 2023-08-02 — Teas voluntary amendment received
  • 2023-12-31 — Assigned to lie
  • 2023-12-31 — Preliminary/voluntary amendment - entered
  • 2024-01-10 — Assigned to examiner
  • 2024-01-10 — Letter of protest evidence reviewed-no further action taken
  • 2024-01-10 — Approved for registration supplemental register
  • 2024-02-13 — Registered-supplemental register
  • 2024-02-13 — Notice of registration confirmation emailed
  • 2024-08-30 — Cancellation instituted no. 999999
  • 2025-09-29 — Cancellation granted no. 999999
  • 2025-11-17 — Cancellation terminated no. 999999
  • 2025-11-17 — Cancelled section 18-total
  • 2025-11-17 — Final status recorded

Owner Information

Allogene Therapeutics, Inc.
South San Francisco , CA
Allogene Therapeutics, Inc.
South San Francisco , CA

Correspondent

THOMAS L. HOLT PERKINS COIE LLP
P.O. BOX 2608
SEATTLE, WA 98111
UNITED STATES

Filing Details

Filing Date:
2023-04-14
Status Date:
2025-11-17
Category:
Pharmaceuticals
Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.